InnovaMatrix FS is a sterile, single use, medical device consisting of extracellular matrix derived from porcine placental material used for safe and effective wound treatment.
INTENDED USES: InnovaMatrix FS is intended for use in the management of wounds, including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor site/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds, (abrasions, lacerations, second-degree burns and skin tears), and draining wounds.
CLAIMED BENEFITS: InnovaMatrix FS is composed of collagen, elastin, laminin, fibronectin, hyaluronic acid and sulfated glycosaminoglycans and is produced in fenestrated sheetsin a variety of sizes. This biodegradable wound matrix provides a protective cover to the wound. It is applied on a wound after the wound bed is prepared with standard debridement methods. The product will fully resorb and does not have to be removed. InnovaMatrix AC is supplied terminally sterile, in a single use package, and in a variety of sizes of fenestrated sheets.
OPTIONS: Per Square Centimeter
Wound Reference does not produce, market, re-sell or distribute health care goods or services consumed by, or used on, patients.
